Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jul 10;18(1):310.
doi: 10.1186/s13063-017-2029-x.

Warm-needling acupuncture and medicinal cake-separated moxibustion for hyperlipidemia: study protocol for a randomized controlled trial

Affiliations
Randomized Controlled Trial

Warm-needling acupuncture and medicinal cake-separated moxibustion for hyperlipidemia: study protocol for a randomized controlled trial

Mailan Liu et al. Trials. .

Abstract

Background: Acupuncture and moxibustion has been widely applied to hyperlipidemia treatment in clinical practice in China, serving as an alternative treatment to statins. Warm-needling acupuncture and medicinal cake-separated moxibustion have been separately reported with potential therapeutic effects on hyperlipidemia treatment in several studies but with limitations in study methodology. Combining these two modalities may provide a more advantageous strategy in treating hyperlipidemia. Therefore, a strict evaluation through well-designed randomized controlled trials (RCT) is necessary to determine their efficacy and safety on hyperlipidemia.

Methods: The study a multicenter, open-label, randomized, stratified, active-controlled, noninferiority trial with two parallel groups. Subjects with hyperlipidemia will be stratified into different groups by risk levels of heart diseases. They then will be instructed to the Therapeutic Lifestyle Change (TLC) diet. Those who have not reached the target lipid level will be randomly assigned to the treatments of either acupuncture and moxibustion or simvastatin with a 1:1 allocation. One hundred and thirty subjects are aimed to be recruited. The duration of intervention for this study will be 12 weeks, followed by another 4 weeks for post-treatment assessment. The primary outcome is percentage change from baseline to the end of the study in low-density lipoprotein cholesterol (LDL-C). Other indicators in lipid change, safety and adherence will also be assessed secondarily. The repeated measures, linear mixed-effects model will be applied to the analysis.

Discussion: Acupuncture and moxibustion could be a potentially effective treatment alternative for hyperlipidemia. A study with careful design is developed to evaluate the efficacy and safety of combined acupuncture and moxibustion, by integrating the traditional Chinese Medicine (TCM) regimens with the standardized Western medicine appraisal approach.

Trial registration: ClinicalTrials.gov, NCT02269046 . Registered on 26 September 2014.

Keywords: Acupuncture; Hyperlipidemia; Medicinal cake-separated moxibustion; Moxibustion; Randomized controlled trial; Traditional Chinese medicine; Warm-needling acupuncture.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
SPIRIT Figure for schedule of enrolment, interventions, and assessments of the AMHRCTstudy
Fig. 2
Fig. 2
Treatment regimen flowchart. This figure demonstrates the treatment regimen and flowchart for intervention of warm needling and medicinal cake-separated moxibustion
Fig. 3
Fig. 3
Trial flowchart. This figure provides an overview of participant flow in this trial

Similar articles

Cited by

References

    1. Reiner Z. Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol. 2013;10:453–464. doi: 10.1038/nrcardio.2013.80. - DOI - PubMed
    1. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease, The Cochrane Library. 2013. - PMC - PubMed
    1. Farnier M, Davignon J. Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol. 1998;82:3J–10J. doi: 10.1016/S0002-9149(98)00423-8. - DOI - PubMed
    1. Feingold K. Statin therapy in hyperlipidemia: balancing the risk and benefits. 2014.
    1. 张宝珍, 张凯, 刘玉珍. 针灸丰隆治疗高脂血症临床随机对照试验 Meta 分析. 中国中医药信息杂志 2014;21:11-15.

Publication types

MeSH terms

Associated data